IFIH1 and interstitial lung disease: Although several serum risk factors, including anti-MDA5 antibody titer, CRP, LDH, and SF [18–20], are thought to be associated with the development of ILD in MDA5+ patients, however, they are not a good predictor of the occurrence of RP-ILD.